REFRAMING MS

Living with MS can be hard, but your treatment doesn't have to be. That's why it's so important to speak up, and ask questions when it comes to finding the treatment that works best for you. It can be scary at first, but working closely with your doctor to manage RMS on your terms can help you regain a sense of control over your health.

WATCH JAMIE LYNN’S INSPIRATIONAL STORY

Learn how she used her voice and found strength to manage RMS on her terms.

From Staying Quiet to Speaking Up

“I kept my relapsing MS hidden for years for a lot of reasons—and it robbed me of the support I really needed. When I finally had the courage to open up about it, I learned how important it is to advocate for myself—including talking to my MS specialist. Honestly, it’s been liberating to be able to speak my truth.

My doctor helped me realize that my voice should be the loudest in the room—and it is. Taking charge and speaking up about what I want and need from my treatment helped us choose KESIMPTA."

Why KESIMPTA Is Jamie Lynn’s Right Fit

"As a mom, wife, and actor, I'm pulled in a lot of directions and need a treatment that can fit my demanding lifestyle. When I spoke up about that with my doctor, he mentioned KESIMPTA. We discussed the trial results and safety profile,* and how I could take it once a month^† at home. I was impressed. So together, we decided I’d make the switch.

Since starting KESIMPTA, I’m even more confident in my choice. It fits perfectly into my packed calendar, and I can stay on top of my treatment and feel in control of where I take it, even when I’m traveling for work or with my kids. I love how you can take it at home or take it with you—the flexibility has been a game changer for me.”
 

Up Next:

Discover why more and more people are choosing KESIMPTA.

Jamie Lynn S. has taken KESIMPTA and has been compensated for her time.
MS, multiple sclerosis; RMS, relapsing multiple sclerosis.
*In 2 studies vs teriflunomide.
^†Once monthly after 3 weekly starter doses.
^‡Limitations apply. Valid only for those with private insurance. The Program includes the Co-Pay Plus offer, Plus Card (if applicable), and Rebate, with a combined annual limit up to $18,000. Patient is responsible for any costs once limit is reached in a calendar year. Program not valid (i) under Medicare, Medicaid, TRICARE, VA, DoD, or any other federal or state health care program, (ii) where patient is not using insurance coverage at all, (iii) where the patient’s insurance plan reimburses for the entire cost of the drug, or (iv) where product is not covered by patient’s insurance. The value of this program is exclusively for the benefit of patients and is intended to be credited towards patient out-of-pocket obligations and maximums, including applicable co-payments, coinsurance, and deductibles. Program is not valid where prohibited by law. Patient may not seek reimbursement for the value received from this program from other parties, including any health insurance program or plan, flexible spending account, or health care savings account. Patient is responsible for complying with any applicable limitations and requirements of their health plan related to the use of the Program. Valid only in the United States and Puerto Rico. This Program is not health insurance. Program may not be combined with any third-party rebate, coupon, or offer. Proof of purchase may be required. Novartis reserves the right to rescind, revoke, or amend the Program and discontinue support at any time without notice. See complete Terms & Conditions at start.kesimpta.com.
^§2025 data on file.